Director/PDMR Shareholding

RNS Number : 9718U

Dechra Pharmaceuticals PLC

25 October 2010

 



Dechra Pharmaceuticals PLC

("the Company")

25 October 2010

Director / PDMR Shareholding

Dechra Pharmaceuticals PLC ("the Company") has been notified that on 25 October 2010 Ian Page, Chief Executive, transferred 2,000 shares in the Company to his son, David Mark Page, for nil consideration.

The total beneficial holding of Ian Page following this transaction is unchanged, being 707,731 shares, which represents 1.07% of current issued share capital.

 

END

 

 

RDSKKPDNPBDDOKB